Items where authors include "Driscoll, CB"

Article

Kottke, T, Tonne, J, Evgin, L et al. (19 more authors) (2021) Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy. Nature Communications, 12 (1). 1930. ISSN 2041-1723

Driscoll, CB, Schuelke, MR, Kottke, T et al. (17 more authors) (2020) APOBEC3B-mediated Corruption of the Tumor Cell Immunopeptidome Induces Heteroclitic Neoepitopes for Cancer Immunotherapy. Nature Communications, 11. 790. ISSN 2041-1723

Schuelke, MR, Wongthida, P, Thompson, J et al. (8 more authors) (2019) Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for ImmunoTherapy of Cancer, 7 (1). 188. ISSN 2051-1426

Huff, AL, Wongthida, P, Kottke, T et al. (12 more authors) (2018) APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular Therapy - Oncolytics, 11. pp. 1-13.

Shim, KG, Zaidi, S, Thompson, J et al. (8 more authors) (2017) Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy. Molecular Therapy, 25 (4). pp. 962-975. ISSN 1525-0016